SCHULMAN MICHAEL

Historique de performance de SCHULMAN MICHAEL

Historique insuffisant pour un historique de performance statistique (moins de 5 achats sur le marché).

Historique des transactions de SCHULMAN MICHAEL

Co-initiés de SCHULMAN MICHAEL

• Angermayer ChristianFaeth Therapeutics, Inc.
• Apeiron Investment Group Ltd.Faeth Therapeutics, Inc.
• Broder SamuelFaeth Therapeutics, Inc.
• Cambrian BioPharma IncFaeth Therapeutics, Inc.
• Celebi JohnFaeth Therapeutics, Inc.
• Colgan ErinFaeth Therapeutics, Inc.
• Craver JosiahFaeth Therapeutics, Inc.
• DONENBERG PHILIP BFaeth Therapeutics, Inc.
• ENGLANDER ISRAEL AFaeth Therapeutics, Inc.
• English JessieFaeth Therapeutics, Inc.
• Fjaellskog Marie-LouiseFaeth Therapeutics, Inc.
• Gaiero David GFaeth Therapeutics, Inc.
• Gallagher Patrick StephenFaeth Therapeutics, Inc.
• Gerry ChristopherFaeth Therapeutics, Inc.
• Hahn Stephen M.Faeth Therapeutics, Inc.
• Hoey AnupamaFaeth Therapeutics, Inc.
• Holmen BobFaeth Therapeutics, Inc.
• H&S INVESTMENTS I LPFaeth Therapeutics, Inc.
• H&S VENTURES LLCFaeth Therapeutics, Inc.
• Humer KristianFaeth Therapeutics, Inc.
• ICS OPPORTUNITIES II LLCFaeth Therapeutics, Inc.
• Khosla Ventures Associates VI, LLCFaeth Therapeutics, Inc.
• Khosla Ventures Seed Associates D, LLCFaeth Therapeutics, Inc.
• Khosla Ventures Seed D, L.P.Faeth Therapeutics, Inc.
• Khosla Ventures VI, L.P.Faeth Therapeutics, Inc.
• KHOSLA VINODFaeth Therapeutics, Inc.
• Krebs StephanieFaeth Therapeutics, Inc.
• MILLENNIUM INTERNATIONAL MANAGEMENT GP LLCFaeth Therapeutics, Inc.
• MILLENNIUM MANAGEMENT, L.L.C.Faeth Therapeutics, Inc.
• Parikh Anand KiranFaeth Therapeutics, Inc.
• Peyer JamesFaeth Therapeutics, Inc.
• Pierce Robert HamiltonFaeth Therapeutics, Inc.
• Presight Co-Invest Management, L.L.C.Faeth Therapeutics, Inc.
• Presight Sensei Co-Invest Fund, L.P.Faeth Therapeutics, Inc.
• Ramasastry SairaFaeth Therapeutics, Inc.
• RICKS THOMAS GFaeth Therapeutics, Inc.
• RINGO WILLIAM RFaeth Therapeutics, Inc.
• SAMUELI HENRYFaeth Therapeutics, Inc.
• SAMUELI SUSANFaeth Therapeutics, Inc.